3rd Annual Cell & Gene Therapy Congress


6 - 7 November 2017, London

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions. Over 20 presentations and case studies focused on the key issues in cell & gene therapy development, updates in regulatory pathways, commercialisation, bioprocessing and manufacturing.